Phase II Study of Gemcitabine + S-1 in Elderly Patients With Non-Small Cell Lung Cancer
Phase 2
- Conditions
- non-small cell lung cancer
- Registration Number
- JPRN-UMIN000001032
- Lead Sponsor
- ational Hospital Organization Lung Cancer Study Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 35
Inclusion Criteria
Not provided
Exclusion Criteria
1)No interstitial pneumonia or pulmonary fibrosis, as determined by chest x-ray 2)A history of severe allergic reactions to drugs 3) Patients with concurrent serious infections or complications are excluded 4) Clinically significant pleural/pericardial effusion which requires drainage before study entry. 5) Patients with an unstable or serious heart disease 6) Inadequately controlled diabetes mellitus 7) Symptomatic brain metastases 8) The presence of other concomitant or metachronous cancers 9)Any concomitant pathology that would, in the investigator`s opinion, contraindicate the use of the drugs in the protocol
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method progression-free survival
- Secondary Outcome Measures
Name Time Method compliance, safety, response rate, overall survival time